48 pending office actions • 4 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Roche Diagnostics Operations, Inc. | 45 |
| Mochida Pharmaceutical Co., Ltd. | 1 |
| Roche Diagnostics Operations, Inc. | 1 |
| Roche Sequencing Solutions, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18726309 | METHOD FOR OPERATING LABORATORY SYSTEM AND LABORATORY SYSTEM | Roche Diagnostics Operations, Inc. | TOMASZEWSKI, MICHAEL | 3681 | Non-Final OA | Jul 02, 2024 |
| 18755464 | DETECTION OF AIR BUBBLES IN OPTICAL DETECTION UNIT | Roche Diagnostics Operations, Inc. | BENNETT, JENNIFER D | 2878 | Non-Final OA | Jun 26, 2024 |
| 18667208 | OPTICAL SYSTEM FOR FOURIER PTYCHOGRAPHY | Roche Diagnostics Operations, Inc. | HUANG, WEN | 2872 | Non-Final OA | May 17, 2024 |
| 18656996 | LABORATORY SAMPLE CONTAINER CARRIER HANDLING APPARATUS, LABORATORY AUTOMATION SYSTEM, AND USE | Roche Diagnostics Operations, Inc. | WHATLEY, BENJAMIN R | 1798 | Final Rejection | May 07, 2024 |
| 18649151 | TRANSPORT DEVICE AND LABORATORY SAMPLE DISTRIBUTION SYSTEM | Roche Diagnostics Operations, Inc. | JORGENSEN, ABBY A | 3651 | Final Rejection | Apr 29, 2024 |
| 18566548 | AN ANALYZER SYSTEM | Roche Diagnostics Operations, Inc. | LI, LARRY | 2881 | Non-Final OA | Dec 01, 2023 |
| 18561621 | sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS | Roche Diagnostics Operations, Inc. | COUNTS, GARY W | 1678 | Non-Final OA | Nov 16, 2023 |
| 18560126 | METHOD FOR OPERATING A LABORATORY AUTOMATION SYSTEM, LABORATORY AUTOMATION SYSTEM, AND LABORATORY IN-VITRO DIAGNOSTIC SYSTEM | Roche Diagnostics Operations, Inc. | BROTHERS, LAURENCE RAPHAEL | 3655 | Non-Final OA | Nov 10, 2023 |
| 18506002 | TRANSGLUTAMINASE SUBSTRATES FOR LABELING | Roche Diagnostics Operations, Inc. | CHESTNUT, BARRY A | 1672 | Non-Final OA | Nov 09, 2023 |
| 18558133 | IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS | Roche Diagnostics Operations, Inc. | LANKFORD JR, LEON B | 1657 | Non-Final OA | Oct 30, 2023 |
| 18558150 | ESM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS | Roche Diagnostics Operations, Inc. | LANKFORD JR, LEON B | 1657 | Non-Final OA | Oct 30, 2023 |
| 18557890 | PRESEPSIN MARKER PANELS FOR EARLY DETECTION OF SEPSIS | Mochida Pharmaceutical Co., Ltd. | LANKFORD JR, LEON B | 1657 | Non-Final OA | Oct 27, 2023 |
| 18556849 | INFORMATION PROCESSING DEVICE FOR PROVIDING REFERENCE INFORMATION RELATING TO DIAGNOSIS OF THYROID DISEASE | Roche Diagnostics Operations, Inc. | HRANEK, KAREN AMANDA | 3684 | Non-Final OA | Oct 23, 2023 |
| 18478291 | PSP94 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Roche Diagnostics Operations, Inc. | MUTREJA, JYOTI NAGPAUL | 1798 | Non-Final OA | Sep 29, 2023 |
| 18352183 | PROGNOSTIC VALUE OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HAVING STABLE DISEASE | Roche Diagnostics Operations, Inc. | SINES, BRIAN J | 1796 | Non-Final OA | Jul 13, 2023 |
| 18339760 | AUTOMATED CLINICAL DIAGNOSTIC SYSTEM AND METHOD | Roche Diagnostics Operations, Inc. | WALLENHORST, MAUREEN | 1797 | Non-Final OA | Jun 22, 2023 |
| 18337018 | LC-MS METHOD FOR DETECTING AND QUANTIFYING 11-OXYGENATED STEROIDS | Roche Diagnostics Operations, Inc. | SODERQUIST, ARLEN | 1797 | Non-Final OA | Jun 18, 2023 |
| 18328104 | DETECTION OF AN ANALYTE OF INTEREST BY CROSS SPRAY ESI MASS SPECTROMETRY | Roche Diagnostics Operations, Inc. | STOFFA, WYATT A | 2881 | Final Rejection | Jun 02, 2023 |
| 18312442 | DERIVATIZATION OF AT LEAST ONE ANALYTE OF INTEREST FOR MASS SPEC MEASUREMENTS IN PATIENT SAMPLES | Roche Diagnostics Operations, Inc. | XU, XIAOYUN | 1797 | Non-Final OA | May 04, 2023 |
| 18309985 | TIMP1 AS A MARKER FOR CHOLANGIOCARCINOMA | Roche Diagnostics Operations, Inc. | DENT, ALANA HARRIS | 1643 | Non-Final OA | May 01, 2023 |
| 18306195 | DETECTION OF AN ANALYTE OF INTEREST BY NANOESI MASS SPECTROMETRY | Roche Diagnostics Operations, Inc. | FRITCHMAN, REBECCA M | 1758 | Final Rejection | Apr 24, 2023 |
| 18299750 | GRIPPING APPARATUS FOR GRIPPING SAMPLE CONTAINER | Roche Diagnostics Operations, Inc. | LEEDS, DANIEL JEREMY | 3731 | Non-Final OA | Apr 13, 2023 |
| 18028235 | CIRCULATING TOTAL-NT-PROBNP (GLYCOSYLATED AND UNGLYCOSYLATED NT-PROBNP) AND ITS RATIO WITH NT-PROBNP (UNGLYCOSYLATED NT-PROBNP) IN THE ASSESSMENT OF ATRIAL FIBRILLATION | Roche Diagnostics Operations, Inc. | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Mar 24, 2023 |
| 18028245 | BACTERIAL PILUS PROTEIN COMPLEX FIMGT-DSF STABILIZED PROTEIN COMPLEXES FOR PRODUCING FILAMENTOUS PHAGES | Roche Diagnostics Operations, Inc. | ZOU, NIANXIANG | 1671 | Non-Final OA | Mar 24, 2023 |
| 18125708 | METHOD FOR DETERMINING THE LEVEL OF VITAMIN D AND METABOLITES THEREOF | Roche Diagnostics Operations, Inc. | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Mar 23, 2023 |
| 18171469 | METHOD FOR SENSOR CALIBRATION | Roche Diagnostics Operations, Inc. | GERHARD, ALISON CLAIRE | 1797 | Non-Final OA | Feb 20, 2023 |
| 18021047 | ESM-1 FOR THE ASSESSMENT OF SILENT BRAIN INFARCTS AND COGNITIVE DECLINE | Roche Diagnostics Operations, Inc. | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Feb 13, 2023 |
| 18021085 | IGFBP7 FOR THE ASSESSMENT OF SILENT BRAIN INFARCTS AND COGNITIVE DECLINE | Roche Diagnostics Operations, Inc. | WEIDNER, ADAM M | 1675 | Non-Final OA | Feb 13, 2023 |
| 18021021 | MULTIMARKER PANEL FOR THE ASSESSMENT OF SILENT BRAIN INFARCTS AND COGNITIVE DECLINE | Roche Diagnostics Operations, Inc. | SAOUD, CHRISTINE J | 1645 | Non-Final OA | Feb 13, 2023 |
| 17916251 | A METHOD OF ASSESSING A FEMALE'S RISK OF HAVING PCOS AS WELL AS PRODUCTS AND USES RELATING THERETO | Roche Diagnostics Operations, Inc. | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | Non-Final OA | Sep 30, 2022 |
| 17907039 | CORONA NUCLEOCAPSID ANTIGEN FOR USE IN ANTIBODY-IMMUNOASSAYS | Roche Diagnostics Operations, Inc. | JOHANSEN, PETER N. | 1644 | Non-Final OA | Sep 22, 2022 |
| 17931993 | CARRY-OVER MONITORING | Roche Diagnostics Operations, Inc. | HILL, GRACELYN MARKHAM | 1685 | Non-Final OA | Sep 14, 2022 |
| 17821951 | TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION | Roche Diagnostics Operations, Inc. | COUNTS, GARY W | 1678 | Final Rejection | Aug 24, 2022 |
| 17891458 | IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING | Roche Diagnostics Operations, Inc. | MARCSISIN, ELLEN JEAN | 1677 | Non-Final OA | Aug 19, 2022 |
| 17838568 | PARTICLE-BASED IMMUNOASSAY USING A PEGYLATED ANALYTE-SPECIFIC BINDING AGENT | Roche Diagnostics Operations, Inc. | NGUYEN, NAM P | 1678 | Non-Final OA | Jun 13, 2022 |
| 17772959 | SEPSIS MANAGEMENT | Roche Diagnostics Operations, Inc. | COUNTS, GARY W | 1678 | Non-Final OA | Apr 28, 2022 |
| 17575120 | S100A9 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Roche Diagnostics Operations, Inc. | IVICH, FERNANDO NMN | 1678 | Final Rejection | Jan 13, 2022 |
| 17575202 | S100A12 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Roche Diagnostics Operations, Inc. | MONTGOMERY, ANN Y | 1678 | Non-Final OA | Jan 13, 2022 |
| 17575137 | SUBSTANCE P AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Roche Diagnostics Operations, Inc. | IVICH, FERNANDO NMN | 1678 | Final Rejection | Jan 13, 2022 |
| 17643559 | SENSOR DEVICE AND METHOD OF USE | Roche Diagnostics Operations, Inc. | WOITACH, JOSEPH T | 1687 | Final Rejection | Dec 09, 2021 |
| 17447844 | METHOD FOR DETERMINING AT LEAST ONE STATE OF AT LEAST ONE CAVITY OF A TRANSPORT INTERFACE CONFIGURED FOR TRANSPORTING SAMPLE TUBES | Roche Diagnostics Operations, Inc. | SKIBINSKY, ANNA | 1635 | Final Rejection | Sep 16, 2021 |
| 17360121 | DETECTION OF BACTERIAL (MOLLICUTIES) CONTAMINATION | Roche Diagnostics Operations, Inc. | BERTAGNA, ANGELA MARIE | 1681 | Non-Final OA | Jun 28, 2021 |
| 17350822 | METHODS FOR DETECTING AN ANALYTE USING STRUCTURE SWITCHING BINDING AGENTS | Roche Sequencing Solutions, Inc. | LIRIANO, MELISSA LIZETTE | 1677 | Non-Final OA | Jun 17, 2021 |
| 17186163 | THYMIDINE KINASE (TK-1) IN PROGNOSTIC INDICES FOR DLBCL | Roche Diagnostics Operations, Inc. | PULLIAM, JOSEPH CONSTANTINE | 1687 | Final Rejection | Feb 26, 2021 |
| 17162140 | Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure | Roche Diagnostics Operations, Inc. | MARCSISIN, ELLEN JEAN | 1677 | Non-Final OA | Jan 29, 2021 |
| 17126439 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | Roche Diagnostics Operations, Inc. | ANGELL, JON E | 1637 | Final Rejection | Dec 18, 2020 |
| 16008281 | FKBP DOMAIN WITH TRANSGLUTAMINASE RECOGNITION SITE | Roche Diagnostics Operations, Inc. | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Jun 14, 2018 |
| 15892829 | ALKALINE PRETREATMENT OF PARVOVIRUSES FOR IMMUNOASSAYS | Roche Diagnostics Operations, Inc. | NGUYEN, NAM P | 1678 | Final Rejection | Feb 09, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial